Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer.

Published in: The Annals of pharmacotherapy (2020)

Sacituzumab govitecan is a novel targeted treatment with promising activity in mTNBC.

Keyphrases